Aspirin-Exacerbated Cutaneous Disease

Immunology and Allergy Clinics of North America

Volumn 33, Issue 2, 2013, Pages 251-262

  Sánchez Borges, Mario ^a   Caballero Fonseca, Fernan ^a   Capriles Hulett, Arnaldo ^a  

^a Centro Medico Docente La Trinidad   (Venezuela)

Author keywords

Angioedema; Aspirin; Chronic urticaria; Cyclooxygenases; Leukotrienes; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CELECOXIB; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPYRONE; ETORICOXIB; FEXOFENADINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; KETOPROFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; MELOXICAM; NAPROXEN; NIMESULIDE; NITAZOXANIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISONE; ROFECOXIB; UNINDEXED DRUG;

ADD ON THERAPY; ANGIONEUROTIC EDEMA; ARACHIDONIC ACID METABOLISM; ASPIRIN EXACERBATED CUTANEOUS DISEASE; ASPIRIN INDUCED CUTANEOUS DISEASE; CHRONIC INFLAMMATION; CHRONIC URTICARIA; CROSS REACTION; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG RECHALLENGE; EDEMA; EYELID EDEMA; FACE EDEMA; FEVER; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; LIP DISEASE; LIP EDEMA; MEDICAL HISTORY; PAIN; PATHOGENESIS; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; RECOMMENDED DRUG DOSE; REVIEW; SKIN BIOPSY; TONGUE EDEMA; TOOTH PAIN; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG HYPERSENSITIVITY; HUMANS; SKIN DISEASES;

EID: 84877016393     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.10.004     Document Type: Review

References (46)

1. Gomes C.R., Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005, 5:309-316.
2. Stevenson D. Challenge procedures in detection of reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1993, 71:117-118.
3. Stevenson D.D., Sánchez-Borges M., Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenase enzymes. Ann Allergy Asthma Immunol 2001, 87:1-4.
4. Kowalski M.L., Makowska J.S., Blanca M., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011, 66:818-829.
5. Sánchez-Borges M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am 2010, 94:853-864.
6. Chandrasekharan N.V., Dai H., Roos K.L., et al. COX-3 a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci U S A 2002, 99:13926-13931.
7. Simmons D.L., Botting R.M., Robertson P.M., et al. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroidal anti-inflammatory drugs. Proc Natl Acad Sci U S A 1999, 96:3275-3280.
8. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64:1417-1426.
9. Kaplan A. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002, 346:175-179.
10. Quiralte J., Blanco C., Delgado J., et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced reactions. J Investig Allergol Clin Immunol 2007, 17:182-188.
11. Quiralte J., Blanco C., Castillo R., et al. Intolerance to non-steroidal anti-inflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996, 98:678-685.
12. Moore-Robinson M., Warin R.P. Effect of salicylates in urticaria. Br Med J 1967, 4:262-264.
13. Settipane R.A., Constantine H.P., Settipane G.A. Aspirin intolerance and recurrent urticaria in normal adults and children. Allergy 1980, 35:149-154.
14. Grattan C.E. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003, 28:123-127.
15. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003, 111:1095-1098.
16. Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol 2004, 31:376-382.
17. Doeglas H.M. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975, 93:135-144.
18. Mastalerz L., Setkowicz M., Szczeklik A. A mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep 2005, 5:277-283.
19. Zembowicz A., Mastalerz L., Setkowicz M., et al. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003, 139:1577-1582.
20. Asero R. Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. Clin Exp Dermatol 2007, 32:661-663.
21. Bae J.S., Kim S.H., Ye Y.M., et al. Significant association of FcεRIα promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007, 119:449-456.
22. Kim S.H., Ye Y.M., Palikhe N.S., et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010, 10:280-290.
23. Sánchez-Borges M., Capriles-Hulett A., Caballero-Fonseca F., et al. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001, 87:201-204.
24. Mastalerz L., Setkowicz M., Sanak M., et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004, 113:771-775.
25. Setkowicz M., Mastalerz L., Podolec-Rubis M., et al. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009, 123:174-178.
26. Perez C., Sánchez-Borges M., Suárez-Chacón R. Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 2001, 108:1060-1061.
27. Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000, 85:156-157.
28. Leznoff A., Josse R.G., Denburg J., et al. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983, 119(8):636-640.
29. Gruber B., Baeza M., Marchese M., et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988, 90:213-217.
30. Hide M., Francis D., Grattan C., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599-1604.
31. Asero R. Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol 2007, 144:226-230.
32. Ye Y.M., Hur G.Y., Park H.J., et al. Association of specific IgE to staphylococcal superantigens with the phenotype of chronic urticaria. J Korean Med Sci 2008, 23:845-851.
33. Pacor M.L., Di Lorenzo G., Mansueto P., et al. Relationship between human leukocyte antigen class I and class II and chronic idiopathic urticaria associated with aspirin and/or NSAID hypersensitivity. Mediat Inflamm 2006, 1-5. article ID 62489.
34. Kim S.Y., Park H.S. Genetic markers for differentiating aspirin hypersensitivity. Yonsei Med J 2006, 47:15-21.
35. Sánchez-Borges M., Acevedo N., Vergara C., et al. The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol 2009, 19:375-382.
36. Isik S.R., Karakaya G., Celikel S., et al. Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates. Int Arch Allergy Immunol 2009, 150:299-306.
37. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L., et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007, 62:1111-1118.
38. Messaad D., Sahla H., Benahmed S., et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004, 140:1001-1006.
39. Sanz M.L., Gamboa P., De Weck A.L. A new combined test with flow cytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005, 136:58-72.
40. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64:1427-1443.
41. Sánchez-Borges M, Asero R, Ansotegui IJ, et al. World Allergy Organization position paper. Diagnosis and treatment of urticaria and angioedema-a worldwide perspective. World Allergy Organ J 2012; in press.
42. Saini S., Rosen K.E., Hsieh H.J., et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H(1)-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011, 128:567-573.
43. Kessel A., Toubi E. Cyclosporine-a in severe chronic urticaria: the option for long-term therapy. Allergy 2010, 65:1478-1482.
44. Sánchez-Borges M., Caballero-Fonseca F., Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol 2005, 94:34-38.
45. Sánchez-Borges M., Caballero-Fonseca F., Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005, 95:154-158.
46. Simon R.A. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol 2003, 24:189-198.